Hyperuricemia
Hyperuricemia
Hyperuricemia is persistent elevation of uric acid in blood, often silent at first but tied to gout, kidney stones, and cardiometabolic risks. This category outlines medicines that lower urate, prevent flares, and relieve inflammation, along with learning resources and related conditions. Shoppers can compare brands, tablet strengths, and common co-therapies, understanding that stock can change by supplier and time. Cross-border fulfillment details, including US shipping from Canada, appear on relevant product pages without guaranteeing availability.Hyperuricemia OverviewHigh uric acid forms when production exceeds removal. The body makes urate from purines, which come from cell turnover and diet. Kidneys usually excrete most urate, while the gut clears the rest. When elimination falls or production rises, crystals can form in joints and tissues. This process can trigger joint inflammation, called a flare, or deposit in kidneys over time.Many people have no symptoms until a sudden, painful attack starts. Risk increases with chronic kidney disease, diuretic use, high-purine diets, dehydration, obesity, and insulin resistance. Some chemotherapy and transplant medicines also shift urate levels. Treatment goals include lowering serum urate to a target, preventing flares during initiation, and managing acute pain safely. Monitoring helps match dose to response, kidney function, and coexisting conditions.What’s in This CategoryThis section covers xanthine oxidase inhibitors, uricosurics, anti-inflammatory agents, and flare-prevention therapies. Xanthine oxidase inhibitors reduce urate production and include Allopurinol and Febuxostat. Uricosurics increase renal urate excretion; a representative option is Probenecid. Flare prevention and treatment may involve Colchicine, nonsteroidal anti-inflammatory drugs, or short steroid tapers. Tablets are the most common form, with multiple strengths for stepwise dosing.Products in this category focus on reducing serum urate and controlling inflammatory episodes. Many approaches are combined during the first months of therapy. When selecting any hyperuricemia medication, clinicians consider kidney function, interaction risks, and comorbidities. Some agents are used as long-term maintenance, while others are short-term supports during flares or dose titration. Availability may vary, and equivalent strengths can differ by brand or manufacturer.How to ChooseSelection starts with current serum urate, flare frequency, kidney function, and coexisting conditions. Clinicians set a target based on the uric acid normal range and individual risk. People with reduced kidney function may need adjusted dosing or alternative agents. History of cardiovascular disease can influence the choice between urate-lowering drugs. Flare risk during initiation guides the need for prophylaxis and an anti-inflammatory plan.Storage, handling, and adherence are practical considerations. Tablets should stay in original containers when possible, away from moisture and heat. Acute pain plans often use NSAIDs like Indomethacin or Naproxen for short periods. Clear titration schedules help achieve targets without overshooting. Discuss potential interactions with diuretics, anticoagulants, and antibiotics before starting any new medicine.Common mistake: starting high doses without flare prophylaxis.Common mistake: stopping early when pain improves but urate remains high.Common mistake: skipping labs after dose changes or new medications.Popular OptionsMany start with a xanthine oxidase inhibitor as baseline urate-lowering therapy. Low-dose starts with slow titration can limit early flares. A short course of Prednisone may be considered when NSAIDs are unsuitable. Ships from Canada to US applies to select items; consult each product page for current specifics. Brands and generics may offer different tablet strengths that support gradual dose changes.Some patients need flare prophylaxis during initiation to prevent painful episodes. Colchicine is commonly used for this role, especially in the first months. For brand familiarity, Zyloprim represents allopurinol in certain markets. Decisions reflect kidney function, past reactions, and concurrent conditions. Acute flare plans should be written out, including stop dates and reassessment steps.Related Conditions & UsesCrystal arthritis is the best-known consequence of high urate. Explore Gout for symptoms, triggers, and long-term management. Some patients experience kidney stone formation due to urate deposition. For additional background on stone risk and prevention strategies, review Uric Acid and Kidney Stones. Blood pressure, lipid disorders, and insulin resistance commonly coexist and can influence medicine choice.Dietary shifts support medicines and reduce flare risk. Resources explaining purine sources, hydration, and weight management can help shape plans. For practical steps that complement therapy, see How to Lower Uric Acid. Guidance complements clinical care for how to reduce uric acid while maintaining balanced nutrition and safe activity levels. Coordination between primary care and specialists improves outcomes when multiple conditions intersect.Authoritative SourcesGeneral testing information, including reference ranges, is outlined by MedlinePlus: Uric acid test overview and interpretation.Regulatory safety communication on febuxostat is available from the FDA: Boxed warning details and clinical context.Health Canada’s Drug Product Database provides monograph access: Search approved products and ingredients.Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.
Filter
Product price
Product categories
Conditions
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
Do I need a prescription for urate-lowering therapy?
Yes, most urate-lowering medicines require a valid prescription. Over-the-counter options mainly address pain and inflammation during flares, not long-term urate control. Prescribers consider kidney function, interactions, and cardiovascular history before choosing a starting agent and dose. Pharmacists may review monitoring plans and timing for lab tests. Refill schedules often align with follow-up labs to track serum urate and safety indices.
Which strengths and forms are commonly available?
Most urate-lowering therapies come as oral tablets in multiple strengths for stepwise titration. Anti-inflammatories and colchicine used for flares or prophylaxis are also typically tablets. Exact strengths vary by product and manufacturer. Labels outline storage needs and handling precautions. Availability can fluctuate by supplier and timing, so product pages list the currently stocked forms and strengths when listed.
Can treatment start during an acute gout flare?
Starting urate-lowering therapy during a flare is possible with adequate anti-inflammatory coverage. Many clinicians begin or continue baseline therapy while treating pain using NSAIDs, colchicine, or a short steroid course. Flare prophylaxis often continues for several months after initiation. Written plans help avoid stopping therapy too early. Follow-up visits confirm progress toward the target serum urate level.
What monitoring is typical after starting therapy?
Monitoring usually includes serum urate, kidney function, and sometimes liver enzymes. Checks occur more often during dose titration and less frequently after reaching target. Clinicians assess flare frequency, adherence, and potential side effects. Dose adjustments are common if the target is not achieved. Clear documentation helps align lab timing with renewals and any changes in concurrent medications.
Related Articles
Weight Management
Zepbound Side Effects Long-Term: Monitoring and Safety
Most Zepbound side effects long-term monitoring focuses on patterns, not panic. Digestive symptoms are common early on and often become easier to predict, while less common warning signs need prompt…
Weight Management
Old Weight Loss Drugs: Safety Lessons for Modern Care
Old weight loss drugs include earlier appetite suppressants, stimulant-like agents, fat-absorption blockers, and discontinued products such as fenfluramine and dexfenfluramine. Some helped shape obesity treatment, but several also exposed serious…
Cardiovascular, Diabetes
National Diabetes Heart Connection Day: Heart Risks and Actions
National Diabetes Heart Connection Day is an awareness day focused on the close link between diabetes and cardiovascular disease. It encourages people with diabetes, caregivers, and care teams to review…
Diabetes
Common Diabetes Medications: Classes, Uses, and Safety
Common diabetes medications lower blood glucose in different ways, so the right choice depends on diabetes type, A1C goals, kidney function, heart health, weight goals, side-effect risk, and personal preferences.…